Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
15.44
-0.03 (-0.19%)
At close: Oct 31, 2025, 4:00 PM EDT
15.57
+0.13 (0.84%)
After-hours: Oct 31, 2025, 5:55 PM EDT
Orthofix Medical Market Cap
Orthofix Medical has a market cap or net worth of $609.79 million as of October 31, 2025. Its market cap has decreased by -0.30% in one year.
Market Cap
609.79M
Enterprise Value
748.92M
1-Year Change
-0.30%
Ranking
Category
Stock Price
$15.44
Market Cap Chart
Since December 1, 1998, Orthofix Medical's market cap has increased from $145.80M to $609.79M, an increase of 318.24%. That is a compound annual growth rate of 5.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 609.80M | -8.60% |
| Dec 31, 2024 | 667.20M | 34.65% |
| Dec 29, 2023 | 495.50M | 20.62% |
| Dec 30, 2022 | 410.80M | -33.08% |
| Dec 31, 2021 | 613.90M | -26.13% |
| Dec 31, 2020 | 831.00M | -5.57% |
| Dec 31, 2019 | 880.00M | -11.40% |
| Dec 31, 2018 | 993.20M | -0.41% |
| Dec 29, 2017 | 997.30M | 54.64% |
| Dec 30, 2016 | 644.90M | -12.93% |
| Dec 31, 2015 | 740.70M | 33.65% |
| Dec 31, 2014 | 554.20M | 24.85% |
| Dec 31, 2013 | 443.90M | -41.58% |
| Dec 31, 2012 | 759.90M | 17.16% |
| Dec 30, 2011 | 648.60M | 26.16% |
| Dec 31, 2010 | 514.10M | -3.00% |
| Dec 31, 2009 | 530.00M | 102.14% |
| Dec 31, 2008 | 262.20M | -73.29% |
| Dec 31, 2007 | 981.70M | 19.78% |
| Dec 29, 2006 | 819.60M | 28.36% |
| Dec 30, 2005 | 638.50M | 4.30% |
| Dec 31, 2004 | 612.20M | -12.12% |
| Dec 31, 2003 | 696.60M | 93.34% |
| Dec 31, 2002 | 360.30M | -26.47% |
| Dec 31, 2001 | 490.00M | 96.63% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.17B |
| Johnson & Johnson | 453.96B |
| AbbVie | 386.89B |
| UnitedHealth Group | 309.57B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 215.71B |